Development of prognostic models for HER2-positive metastatic breast cancer in females: a retrospective population-based study.

BMC Womens Health · 2024 · PMC11687059 · PMID 39736653

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Lapatinib also showed a trend toward better outcomes in patients with brain metastases when no new anti-HER2 agents were available [ 45 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.